New Drug Could Be Used to Treat Prostate Cancer in 2010

Prostate cancer is the most commonly occurring non-skin cancer in the United States today. That is significant considering this type of cancer only affects males. However, prostate cancer has an extremely high survival rate because of new breakthroughs in not only treatment, but also due to early detection. The Associated Press has reported that the
Read More

Mayo Clinic Research Confirms PSA Best Way to Help Diagnose Prostate Cancer

Recent Mayo Clinic research has determined that routine annual evaluation of prostate growth is not solely the best predictor for the development of prostate cancer. According to a recent news report, the recent study suggests that if a man’s prostate specific antigen (PSA) level is rising quickly, a prostate biopsy is a more reasonable way
Read More

Colon Cancer Screening Rates Still Low

A new study published in Health Day News reports that only 61 percent of Americans who should be screened for colon cancer are actually tested. This trend continues despite highly publicized colon cancer awareness campaigns and widespread agreement among medical professionals regarding the prevalence of colorectal cancer, and, the important part that early detection and
Read More

Unnecessary Surgery Because of Test Mix-Up

Cancer misdiagnosis can occur because of hospital error. The Houston Chronicle reported the story of a 35-year-old woman who has filed a medical malpractice claim against a hospital after a mix-up in biopsy results. Essentially, she was told she had cancer when her biopsy, in fact, revealed she did not. The woman not only suffered
Read More